IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: Europe/Mideast

Pfizer eyes AstraZeneca for reported $101 billion

8:12 AM MDT | April 28, 2014 | —Natasha Alperowicz

A recent UK press report says that Pfizer has made initial approaches to acquire AstraZeneca for £60 billion ($101 billion) in what would be the world’s largest pharmaceutical acquisition. The two companies have declined to comment on the report, which appeared in The Sunday Times. A deal between Pfizer and AstraZeneca would create one of the top 10 companies worldwide by market value. AstraZeneca has rejected Pfizer’s overtures, according to the report. AstraZeneca is in a transitional phase, with sales and earnings expected to decline for the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa